Published in Acad Radiol on May 01, 2005
The study of autism as a distributed disorder. Ment Retard Dev Disabil Res Rev (2007) 1.76
Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct (2006) 1.57
Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here. Mol Autism (2011) 1.39
Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies. Transl Psychiatry (2012) 1.08
Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus. Arthritis Rheum (2011) 0.94
Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis. Mol Psychiatry (2014) 0.93
Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders. Biol Psychiatry (2009) 0.92
Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)H-magnetic resonance spectroscopy study of fronto-striato-thalamic regions. J Neural Transm (Vienna) (2009) 0.90
Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI. PLoS One (2012) 0.89
1H MRSI of middle frontal gyrus in pediatric ADHD. J Psychiatr Res (2012) 0.84
From loci to networks and back again: anomalies in the study of autism. Ann N Y Acad Sci (2008) 0.82
Normal Neurochemistry in the Prefrontal and Cerebellar Brain of Adults with Attention-Deficit Hyperactivity Disorder. Front Behav Neurosci (2015) 0.79
Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol Psychiatry (2012) 0.78
A proton spectroscopy study of white matter in children with autism. Prog Neuropsychopharmacol Biol Psychiatry (2015) 0.77
A Comprehensive Review of the (1)H-MRS Metabolite Spectrum in Autism Spectrum Disorder. Front Mol Neurosci (2016) 0.77
Contributions of magnetic resonance spectroscopy to understanding development: potential applications in the study of adolescent alcohol use and abuse. Dev Psychopathol (2014) 0.76
Autism and ADHD: common disorders, elusive explanations. Acad Radiol (2005) 0.76
Candidate Biomarkers in Children with Autism Spectrum Disorder: A Review of MRI Studies. Neurosci Bull (2017) 0.75
The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours. J Neurooncol (2005) 1.05
Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study. Am J Alzheimers Dis Other Demen (2011) 1.00
Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. J Neurol (2014) 0.93
Evidence of brain damage after high-altitude climbing by means of magnetic resonance imaging. Am J Med (2006) 0.92
Evidence of brain dysfunction in attention deficit-hyperactivity disorder: a controlled study with proton magnetic resonance spectroscopy. Acad Radiol (2007) 0.90
Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software. Neurol Res (2009) 0.88
White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination? Acad Radiol (2006) 0.85
Magnetic resonance imaging based clinical research in Alzheimer's disease. J Alzheimers Dis (2012) 0.85
Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas. Acad Radiol (2006) 0.81
Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: clinical and outcome implications. Epilepsy Behav (2009) 0.77
Dystonia induced by gabapentin. Ann Pharmacother (2005) 0.76
Depression in the prodromal phase of Alzheimer disease and the reverse causal hypothesis. Arch Gen Psychiatry (2009) 0.75
Ataxia of Charlevoix-Saguenay: MR and Clinical Results in Lower-Limb Musculature. Can J Neurol Sci (2014) 0.75